Trulicity (dulaglutide) is a prescription antidiabetic injectable medication that belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1).GLP-1 receptor agonists have been shown to lower hemoglobin A1C, an indicator of long-term blood glucose control, by up to 1.6%
HSA/FSA card at checkout: If the pharmacy or telehealth program accepts HSA/FSA cards, just use it like a normal debit card
This sends signals to your brain that youre satisfied, which can reduce your appetite and usually leads to eating fewer calories overall
Given the lack of evidence on safety and long-term use, thats a real concern. Health officials consider loosening peptide regulations In 2023, the FDA changed its classification of some of the most popular peptides including BPC-157, TB-500, CJC-1295 and Ipamorelin citing safety concerns and a lack of evidence
About the author Rekha Kumar, MD, MS, is the head of medical affairs at Found
Routine monitoring should include discussing any new or changed symptoms at your regular diabetes or weight management reviews
